Raia Drogasil stock: Jefferies upgrades Raia Drogasil stock to Buy at BRL 26.00
Published on 10/28/2026 at 06:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Jefferies set a BRL 26.00 target after upgrading Raia Drogasil on October 18, 2026.
- Second-quarter revenue reached BRL 11.06 billion versus BRL 10.83 billion a year earlier.
- Raia Drogasil is scheduled to report third-quarter results on November 3, 2026.
- Market capitalization stood at BRL 27.9 billion on October 28, 2026.
Raia Drogasil (BRRADLACNOR0) was upgraded to Buy by Jefferies, which set a BRL 26.00 price target on October 18, 2026, according to Markets Insider. The move gives the Brazilian pharmacy retailer a fresh analyst catalyst ahead of its next scheduled report.
Why Jefferies changed course
Jefferies paired the upgrade with a BRL 26.00 target, while the cited analyst consensus stood at Hold with an average BRL 23.00 target on October 18, 2026, Markets Insider reported. The difference between the two targets is BRL 3.00, making the upgrade a more constructive view than the published consensus.
Three dated developments
On June 30, 2026, Raia Drogasil reported second-quarter revenue of BRL 11.06 billion and net profit of BRL 424.54 million, compared with BRL 10.83 billion and BRL 374.00 million a year earlier, respectively, according to Markets Insider. On October 18, 2026, Jefferies upgraded the stock and set its BRL 26.00 target. On November 3, 2026, Raia Drogasil is scheduled to release third-quarter results.
What does the next report test?
The June figures imply revenue growth of 2.12 percent year over year and net profit growth of 13.51 percent. The next report will show whether earnings can preserve that spread as the company enters the final quarter of 2026.
Dates and current valuation
The next reporting date is November 3, 2026. InfoMoney lists Raia Drogasil in the B3 third-quarter reporting calendar for that date.
B3 quote and investor lens
Raia Drogasil was trading at BRL 15.94 on B3 on October 28, 2026 at 3:53 p.m. BRT. Its market capitalization was BRL 27.9 billion on the same date, while the 52-week range was BRL 13.50 to BRL 27.42.
Raia Drogasil stock facts
- Company: Raia Drogasil S.A.
- ISIN: BRRADLACNOR0
- Ticker: RADL3
- Primary exchange: B3
- Price B3: BRL 15.94 (as of October 28, 2026, 3:53 p.m. BRT)
- Market capitalization: BRL 27.9 billion (as of October 28, 2026)
- 52-week range: BRL 13.50-27.42 (as of October 28, 2026)
- Sector / Industry: Healthcare / Pharmaceutical Retailers
Market context: Market report Bovespa.
